Nordhealth AS (OSL:NORDH)

Nordhealth AS Statistics

Total Valuation

Nordhealth AS has a market cap or net worth of NOK 2.27 billion. The enterprise value is 2.10 billion.

Market Cap	2.27B
Enterprise Value	2.10B

Important Dates

The last earnings date was Tuesday, May 12, 2026.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Nordhealth AS has 78.81 million shares outstanding.

Current Share Class	44.22M
Shares Outstanding	78.81M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.24%
Owned by Institutions (%)	8.60%
Float	41.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.90
PB Ratio	3.47
P/TBV Ratio	19.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.31
EV / Sales	3.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.20

Financial Position

The company has a current ratio of 1.65

Current Ratio	1.65
Quick Ratio	1.54
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-326.64

Financial Efficiency

Return on equity (ROE) is -23.33% and return on invested capital (ROIC) is -32.59%.

Return on Equity (ROE)	-23.33%
Return on Assets (ROA)	-11.65%
Return on Invested Capital (ROIC)	-32.59%
Return on Capital Employed (ROCE)	-25.14%
Weighted Average Cost of Capital (WACC)	6.04%
Revenue Per Employee	1.27M
Profits Per Employee	-373,618
Employee Count	457
Asset Turnover	0.66
Inventory Turnover	n/a

Taxes

In the past 12 months, Nordhealth AS has paid 5.19 million in taxes.

Income Tax	5.19M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.50% in the last 52 weeks. The beta is 0.33, so Nordhealth AS's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-23.50%
50-Day Moving Average	26.61
200-Day Moving Average	32.76
Relative Strength Index (RSI)	52.59
Average Volume (20 Days)	32,002

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nordhealth AS had revenue of NOK 582.01 million and -170.74 million in losses.

Revenue	582.01M
Gross Profit	139.19M
Operating Income	-165.06M
Pretax Income	-165.56M
Net Income	-170.74M
EBITDA	-87.32M
EBIT	-165.06M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 168.03 million in cash and n/a in debt, with a net cash position of 168.03 million or 2.13 per share.

Cash & Cash Equivalents	168.03M
Total Debt	n/a
Net Cash	168.03M
Net Cash Per Share	2.13
Equity (Book Value)	654.93M
Book Value Per Share	n/a
Working Capital	106.66M

Cash Flow

In the last 12 months, operating cash flow was -17.09 million and capital expenditures -57.45 million, giving a free cash flow of -74.54 million.

Operating Cash Flow	-17.09M
Capital Expenditures	-57.45M
Depreciation & Amortization	74.65M
Net Borrowing	n/a
Free Cash Flow	-74.54M
FCF Per Share	-0.95

Margins

Gross margin is 23.92%, with operating and profit margins of -28.36% and -29.34%.

Gross Margin	23.92%
Operating Margin	-28.36%
Pretax Margin	-28.45%
Profit Margin	-29.34%
EBITDA Margin	-15.00%
EBIT Margin	-28.36%
FCF Margin	n/a

Dividends & Yields

Nordhealth AS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-7.52%
FCF Yield	-3.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2